Evidence map›Paper›PMID 41543451›Full record

ArticleCPT: pharmacometrics & systems pharmacology2026

Pharmacometric-Based Evaluation of Salmeterol and Its Metabolite α-Hydroxysalmeterol in Plasma and Urine: Practical Implications for Doping Control.

Paul Thoueille, Anne Danion, Morten Hostrup, Michael Petrou, Koen Deventer, Thierry Buclin, François R Girardin, Irene Mazzoni, Olivier Rabin, Monia Guidi

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in CPT: pharmacometrics & systems pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Paul ThoueilleService and Laboratory of Clinical Pharmacology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.ORCID https://orcid.org/0000-0002-2305-4277
Anne DanionScience and Medicine Department, World Anti-Doping Agency, Montreal, Quebec, Canada.ORCID https://orcid.org/0009-0001-9360-0798
Morten HostrupDepartment of Nutrition, Exercise and Sports, the August Krogh Section for Human Physiology, University of Copenhagen, Copenhagen, Denmark.ORCID https://orcid.org/0000-0002-6201-2483
Michael PetrouCyprus Anti-Doping Authority, Makarion Athletic Centre Avenue, Engomi, Cyprus.ORCID https://orcid.org/0000-0002-6379-1220
Koen DeventerDoping Control Laboratory (DoCoLab), Ghent University, Department of Diagnostic Sciences (GE32), Ghent, Belgium.ORCID https://orcid.org/0000-0001-8038-1824
Thierry BuclinService and Laboratory of Clinical Pharmacology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.ORCID https://orcid.org/0000-0003-0639-5536
François R GirardinService and Laboratory of Clinical Pharmacology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.ORCID https://orcid.org/0000-0002-0842-927X
Irene MazzoniScience and Medicine Department, World Anti-Doping Agency, Montreal, Quebec, Canada.ORCID https://orcid.org/0000-0002-0658-2596
Olivier RabinScience and Medicine Department, World Anti-Doping Agency, Montreal, Quebec, Canada.ORCID https://orcid.org/0000-0003-3632-0770
Monia GuidiService and Laboratory of Clinical Pharmacology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.ORCID https://orcid.org/0000-0002-6419-9317

Funding

World Anti-Doping Agency
6 · The paper itself

Abstract

Salmeterol is a commonly used β

Indexed as

Adrenergic beta-2 Receptor AgonistsDoping in SportsModels, BiologicalSalmeterol XinafoateAdministration, InhalationAdultFemaleHumansMaleSubstance Abuse DetectionAdrenergic beta-2 Receptor AgonistsSalmeterol Xinafoateanti‐dopingNONMEMpopulation pharmacokineticssalmeterolWADA

Identifiers

PMID41543451
PMCPMC12823318

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.